Idorsia advances global rollout of QUVIVIQ with Jamjoom Pharma partnership in Saudi Arabia and the Levant
Exclusive agreement with Jamjoom Pharma covers commercialization and distribution of QUVIVIQ™ (daridorexant)…
Idorsia confirms successful closing of Pharmakon loan agreement and full repayment of New Money Facility
Allschwil, Switzerland – June 26, 2026Idorsia Ltd (SIX: IDIA), a commercial-stage biopharmaceutical…
Idorsia announces the nomination of three candidates for election to the Board of Directors
Idorsia nominates three Board Directors with outstanding pharmaceutical industry, management and financial…
Idorsias daridorexant in women during menopausal transition age with insomnia
New analysis of a Phase 3 study of daridorexant shows that 50…
